| Literature DB >> 28302143 |
Roel L F van der Palen1,2, Alex J Barker3, Emilie Bollache3, Julio Garcia3,4, Michael J Rose5, Pim van Ooij3,6, Luciana T Young7, Arno A W Roest8, Michael Markl3,9, Joshua D Robinson3,7,10, Cynthia K Rigsby3,5,10.
Abstract
BACKGROUND: Blood flow dynamics make it possible to better understand the development of aortopathy and cardiovascular events in patients with Marfan syndrome (MFS). Aortic 3D blood flow characteristics were investigated in relation to aortic geometry in children and adolescents with MFS.Entities:
Keywords: 4D flow; Aorta hemodynamics; Aortic geometry; Children; Marfan syndrome
Mesh:
Year: 2017 PMID: 28302143 PMCID: PMC5356404 DOI: 10.1186/s12968-017-0345-7
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Aortic 4D flow data processing and analysis. a 4D flow raw data including anatomical and flow data. b volumetric aorta segmentation; levels of aortic diameter measurements. c calculation of systolic 3D WSS vector maps. d regional WSS analysis in ten aortic regions
Fig. 2Aortic 3D blood flow characteristics (systolic streamlines). Panel b represents systolic streamline visualization of a normal aorta from a healthy control. Panels a, c and d illustrate typical secondary flow patterns in Marfan syndrome patients during systole, like a helix flow pattern from the aortic root into the pAAo (a, grade 2) and vortex and helix flow patterns in the pDAo (c, grade 2). d prominent vortex flow patterns in the aortic root
Baseline characteristics
| Marfan | Healthy controls |
| |
|---|---|---|---|
| N (females) | 25 (11) | 21 (12) | 0.375 |
| Age (y) | 15.6 ± 4.0 | 16.0 ± 2.6 | 0.720 |
| Height (cm) | 178.6 ± 17.3 | 161.2 ± 11.2 | <0.001* |
| Weight (kg) | 65.6 ± 20.2 | 58.8 ± 15.1 | 0.208 |
| BSA (m2) | 1.78 ± 0.36 | 1.61 ± 0.25 | 0.082 |
| BMI (kg/m2) | 20.1 ± 4.5 | 22.4 ± 4.0 | 0.081 |
| LV ejection fraction (%) | 55.7 ± 6.5 | 58.1 ± 3.7 | 0.243 |
| Bilateral ectopia lentis ( | 5 (20%) | 0 | |
| Genetic mutation ( | |||
| FBN1 gene | 22 | - | |
| Unknown | 3 | - | |
| Cardiac medication, ( | 20 (80%) | 0 | |
| 1. Beta-blocker | 15 (60%) | - | |
| 2. AT II-receptor antagonist | 7 (28%) | - | |
| 3. ACE inhibitor | 3 (12%) | - | |
| 4. Combination 1 + 2 | 4 (16%) | - | |
| 5. Combination 1 + 3 | 1 (4%) | - | |
| Thoracic aortic size (Z-score) | |||
| Aortic root | 3.56 ± 1.45 | 0.49 ± 0.78 | <0.001* |
| ST-junction | 1.70 ± 1.28 | −0.34 ± 0.77 | <0.001* |
| Ascending aorta | 0.21 ± 0.95 | −0.54 ± 0.64 | 0.004* |
| Distal aortic arch | 0.14 ± 0.90 | −0.23 ± 0.66 | 0.155 |
| Aortic isthmus | 0.96 ± 0.94 | 0.43 ± 0.49 | 0.039* |
| Proximal descending aorta | 2.02 ± 1.60 | 0.56 ± 0.66 | <0.001* |
The p value stems from non-paired t-test, for sex from Chi-square test and for thoracic aorta dimensions from the Mann Whitney test, *p < 0.05. Abbreviations: ACE angiotensin converting enzyme, AT angiotensin, BMI body mass index, BSA body surface area, FBN1 fibrillin-1, LV left ventricular, ST sinotubular
Fig. 3Aortic blood flow streamlines in MFS patients with Z-score ≥ 2.0 of the proximal descending aorta (n = 7). Local vortex flow patterns at the inner curvature of the pDAo (arrows) in six out of the seven MFS patients with dilated pDAo (Z-score ≥ 2.0)
Fig. 4Comparison of mean systolic wall shear stress in the ten aortic regions between groups. a entire MFS cohort (n = 25) vs. healthy subjects (n = 21). b MFS with a pDAo Z-score ≥ 2.0 (n = 7) vs. MFS with a pDAo Z-score < 2.0 (n = 18). c MFS with pDAo Z-score ≥ 2.0 (n = 7) vs. healthy subjects (n = 21)
Fig. 5Relationship between size change and inner wall shear stress in the proximal descending aortic segment. Inverse relation between diameter change between aortic isthmus and pDAo segment (in % of isthmus diameter) and WSSmean of the pDAo segment in MFS patients and healthy subjects
Comparison of aortic dimension and WSS between MFS groups and healthy subjects
| Group 1 | Group 2 | Group 3 | |
|---|---|---|---|
| Age (y) | 15.6 ± 4.5 | 15.6 ± 4.0 | 16.0 ± 2.6 |
| Females ( | 3 | 8 | 12 |
| BSA (m2) | 1.6 ± 0.4 | 1.8 ± 0.3 | 1.6 ± 0.3 |
| Thoracic aortic size (Z-score) | |||
| Z-score Aortic Root** | 4.4 ± 1.3 | 3.2 ± 1.4 | 0.5 ± 0.8 |
| Z-score STJ** | 3.0 ± 0.9 | 1.2 ± 1.0 | −0.3 ± 0.8 |
| Z-score AAo** | 1.1 ± 0.7 | −0.1 ± 0.8 | −0.5 ± 0.6 |
| Z-score distal Arch* | 0.8 ± 0.7 | −0.1 ± 0.9 | −0.2 ± 0.7 |
| Z-score Isthmus** | 2.0 ± 0.7 | 0.6 ± 0.7 | 0.4 ± 0.5 |
| Z-score proximal DAo** | 4.2 ± 1.1 | 1.2 ± 0.6 | 0.6 ± 0.7 |
| Δ diameter Root-AAo (%)** | 30.9 ± 4.0 | 33.8 ± 7.0 | 19.0 ± 7.0 |
| Δ diameter Isthmus-pDAo (%)** | 27.9 ± 9.1 | 10.4 ± 10.1 | 1.9 ± 5.7 |
| WSSmean (Pa) | |||
| 1. Inner pAAo* | 0.69 ± 0.18 | 0.81 ± 0.09 | 0.86 ± 0.16 |
| 2. Outer pAAo | 0.59 ± 0.11 | 0.67 ± 0.11 | 0.73 ± 0.14 |
| 3. Inner dAAo* | 0.85 ± 0.18 | 0.97 ± 0.11 | 0.85 ± 0.15 |
| 4. Outer dAAo | 0.75 ± 0.14 | 0.87 ± 0.11 | 0.83 ± 0.14 |
| 5. Inner Arch | 0.83 ± 0.13 | 0.99 ± 0.13 | 0.91 ± 0.16 |
| 6. Outer Arch | 0.71 ± 0.09 | 0.80 ± 0.11 | 0.79 ± 0.14 |
| 7. Inner pDAo* | 0.58 ± 0.13 | 0.80 ± 0.14 | 0.87 ± 0.21 |
| 8. Outer pDAo | 0.76 ± 0.13 | 0.89 ± 0.10 | 0.86 ± 0.12 |
| 9. Inner dDAo | 0.75 ± 0.09 | 0.89 ± 0.16 | 0.89 ± 0.17 |
| 10. Outer dDAo* | 0.78 ± 0.05 | 0.99 ± 0.18 | 0.97 ± 0.16 |
Significant across subgroups using a Kruskal-Wallis test. *p < 0.05, **p < 0.001. Abbreviations: pAAo proximal ascending aorta, dAAo distal ascending aorta, Arch aortic arch, pDAo proximal descending aorta, dDAo distal descending aorta